Stock HBRM HERBORIUM GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Herborium Group, Inc. Other OTC

Equities

HBRM

US42703A2087

Biotechnology & Medical Research

Business Summary

Herborium Group, Inc. is a developer, licensor and marketer of herbal ingredient-based medicines and wellness products. The Company's flagship product, AcnEase is an herbal, oral treatment for patients with acne or rosacea. The Company serves clients worldwide. It is engaged in the development of a series of the artificial intelligence (AI)-based content products related to dermatological and beauty space. In addition to AcnEase, the Company has secured a pipeline of product candidates. The products include protein skin bar and adjunct cutting age skincare products based on stem cell technology. it is also ready for commercialization of new products line of natural sexual health and performance enhancing products for men and women. The Company owns all formulations for its proprietary products.

Sales per Business

USD in Million2022Weight2023Weight Delta
Botanical Therapeutics
100.0 %
1 100.0 % 1 100.0 % -1.21%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
1 100.0 % 1 100.0 % -1.21%

Managers

Managers TitleAgeSince
Agnes Olszewski CEO
 Chief Executive Officer 67 03/06/02
John Donahue AUD
 Comptroller/Controller/Auditor 74 -

Members of the board

Members of the board TitleAgeSince
Agnes Olszewski CEO
 Chief Executive Officer 67 03/06/02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,919,428,835 10,919,428,835 ( 100.00 %) 0 100.00 %
Stock B 0 4,000,000 0 0

Shareholders

NameEquities%Valuation
Coston, McIsaac & Partners, Inc.
0.000000 %
1 0.000000 % - $

Company contact information

Herborium Group, Inc.

4306 Kenston Place

77459, Missouri City

+

http://www.herborium.com
address Herborium Group, Inc.(HBRM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+8.59% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.80% 104B
BIONTECH SE Stock BioNTech SE
-12.90% 22.41B
ARGENX SE Stock argenx SE
-1.19% 22.28B
GENMAB A/S Stock Genmab A/S
-5.24% 19.07B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-5.05% 17.89B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.57% 14.28B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.84% 12.55B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. HBRM Stock
  4. HBRM Stock
  5. Company Herborium Group, Inc.